Personalized medicine: a personal view.
作者信息
Narod S A
出版信息
Curr Oncol. 2010 Oct;17(5):4-5. doi: 10.3747/co.v17i5.587.
Abstract
摘要
相似文献
1
Personalized medicine: a personal view.
Curr Oncol. 2010 Oct;17(5):4-5. doi: 10.3747/co.v17i5.587.
2
A road toward better education in personalized medicine at universities and beyond.一条通往大学及其他机构实现更优质个性化医疗教育的道路。
Per Med. 2015 Jun;12(3):259-267. doi: 10.2217/pme.14.84.
3
Personalized medicine in Europe: not yet personal enough?欧洲的个性化医疗：个性化程度还不够？
BMC Health Serv Res. 2017 Apr 19;17(1):289. doi: 10.1186/s12913-017-2205-4.
4
A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory.个人视角下的系统医学与主动的 P4 医学的出现：预测性、预防性、个性化和参与性。
N Biotechnol. 2012 Sep 15;29(6):613-24. doi: 10.1016/j.nbt.2012.03.004. Epub 2012 Mar 18.
5
Personal DNA testing in college classrooms: perspectives of students and professors.大学课堂中的个人DNA检测：学生和教授的观点
Genet Test Mol Biomarkers. 2013 Jun;17(6):446-52. doi: 10.1089/gtmb.2012.0404. Epub 2013 Mar 28.
6
The faces of personalized medicine: a framework for understanding its meaning and scope.个性化医学的面貌：理解其含义和范围的框架。
Value Health. 2013 Sep-Oct;16(6 Suppl):S4-9. doi: 10.1016/j.jval.2013.06.005.
7
The future (or lack of future) of personalized prescription in psychiatry.精神病学中个性化处方的未来（或缺乏未来）。
Pharmacol Res. 2009 Feb;59(2):81-9. doi: 10.1016/j.phrs.2008.10.002. Epub 2008 Oct 17.
8
Predictive, Personalized, Preventive and Participatory (4P) Medicine Applied to Telemedicine and eHealth in the Literature.文献中应用于远程医疗和电子健康的预测性、个性化、预防性和参与性（4P）医学。
J Med Syst. 2019 Apr 12;43(5):140. doi: 10.1007/s10916-019-1279-4.
9
Genetics of personalized medicine: cancer and rare diseases.个性化医学的遗传学：癌症和罕见病。
Cell Oncol (Dordr). 2018 Jun;41(3):335-341. doi: 10.1007/s13402-018-0379-3. Epub 2018 Apr 9.
10
Computational challenges of personal genomics.个人基因组学的计算挑战。
Curr Genomics. 2008 Apr;9(2):80-7. doi: 10.2174/138920208784139564.
本文引用的文献
1
Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy.年轻 BRCA1 阳性乳腺癌患者新辅助化疗后的病理完全缓解率。
J Clin Oncol. 2010 Jan 20;28(3):375-9. doi: 10.1200/JCO.2008.20.7019. Epub 2009 Dec 14.
2
Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women.在未选择的犹太女性中筛查 BRCA1 和 BRCA2 的种系突变。
J Clin Oncol. 2010 Jan 20;28(3):387-91. doi: 10.1200/JCO.2009.25.0712. Epub 2009 Dec 14.
3
The contribution of founder mutations to early-onset breast cancer in French-Canadian women.法国裔加拿大女性中早发性乳腺癌的种系突变贡献。
Clin Genet. 2009 Nov;76(5):421-6. doi: 10.1111/j.1399-0004.2009.01277.x.
4
CYP2D6 and tamoxifen: DNA matters in breast cancer.细胞色素P450 2D6与他莫昔芬：DNA在乳腺癌中的重要作用
Nat Rev Cancer. 2009 Aug;9(8):576-86. doi: 10.1038/nrc2683.
5
Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study.安大略省卵巢癌临床基因检测的应用情况：一项基于人群的研究。
Gynecol Oncol. 2009 Jan;112(1):68-72. doi: 10.1016/j.ygyno.2008.10.007. Epub 2008 Nov 20.
6
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.携带BRCA1和BRCA2基因突变者预防性治疗方案的国际应用率差异
Int J Cancer. 2008 May 1;122(9):2017-22. doi: 10.1002/ijc.23340.
7
Direct-to-patient BRCA1 testing: the Twoj Styl experience.直接面向患者的BRCA1基因检测：Twoj Styl体验
Breast Cancer Res Treat. 2006 Dec;100(3):239-45. doi: 10.1007/s10549-006-9261-5. Epub 2006 Jun 29.
8
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.他莫昔芬与携带BRCA1和BRCA2基因者的对侧乳腺癌：最新进展
Int J Cancer. 2006 May 1;118(9):2281-4. doi: 10.1002/ijc.21536.
9
Prevention and management of hereditary breast cancer.遗传性乳腺癌的预防与管理
J Clin Oncol. 2005 Mar 10;23(8):1656-63. doi: 10.1200/JCO.2005.10.035.
10
Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.他莫昔芬与携带BRCA1和BRCA2基因遗传性突变女性的乳腺癌发病率：国家外科辅助乳腺和肠道项目（NSABP-P1）乳腺癌预防试验
JAMA. 2001 Nov 14;286(18):2251-6. doi: 10.1001/jama.286.18.2251.
Zotero 插件